Clinical trial
CALM-AD
NCT00142324 · Institute of Psychiatry, London, Other · Unknown status
Key facts
| NCT number | NCT00142324 |
|---|---|
| Title | CALM-AD |
| Official title | A Randomised Placebo Controlled Trial of a Cholinesterase Inhibitor in the Management of Agitation in Dementia That is Unresponsive to a Psychological Intervention |
| Lead sponsor | Institute of Psychiatry, London, Other |
| Collaborators | Medical Research Council Alzheimer's Society |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Donepezil |
| Enrollment | 190 |
| Start date | Nov 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | Sep 2, 2005 |
| Last update posted | Dec 14, 2005 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: